CLINICAL PHARMACOKINETICS OF DOXORUBICIN

被引：355

作者：

SPETH, PAJ

VANHOESEL, QGCM

HAANEN, C

机构：

[1] UNIV HOSP NIJMEGAN, DEPT MED ONCOL, NIJMEGAN, NETHERLANDS

[2] UNIV HOSP NIJMEGAN, DEPT HEMATOL, NIJMEGAN, NETHERLANDS

来源：

CLINICAL PHARMACOKINETICS | 1988年 / 15卷 / 01期

关键词：

D O I：

10.2165/00003088-198815010-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：15 / 31

页数：17

共 157 条

[111] PHARMACOLOGICAL STUDIES OF INTRAHEPATIC ARTERY CHEMOTHERAPY WITH DEGRADABLE STARCH MICROSPHERES [J].

PFEIFLE, CE ;

HOWELL, SB ;

ASHBURN, WL ;

BARONE, RM ;

BOOKSTEIN, JJ .

CANCER DRUG DELIVERY, 1986, 3 (01) :1-14

[112]

POTMESIL M, 1983, CANCER RES, V43, P3528

[113]

POWIS G, 1985, CANCER CHEMOTH PHARM, V14, P177

[114]

PRAGA C, 1979, CANCER TREAT REP, V63, P827

[115]

PRESANT CA, 1984, CANCER TREAT REP, V68, P651

[116]

RAHMAN A, 1987, P AM SOC CLIN ONCOLO, V6

[117] INFUSION-RATE INDEPENDENT CELLULAR ADRIAMYCIN CONCENTRATIONS AND CYTOTOXICITY TO HUMAN-BONE MARROW CLONOGENIC CELLS (CFU-GM) [J].

RAIJMAKERS, R ;

SPETH, P ;

DEWITTE, T ;

LINSSEN, P ;

WESSELS, J ;

HAANEN, C .

BRITISH JOURNAL OF CANCER, 1987, 56 (02) :123-126

[118]

RAZEK A, 1972, CANCER RES, V32, P1496

[119]

REICH SD, 1976, CANCER RES, V36, P3803

[120]

RIGGS CE, 1983, PHARMACOKINETICS ANT, P229

← 7 8 9 10 11 12 13 14 15 16 →